Clinical evidence update from Animals : an open access journal from MDPI
To help assess the relationship between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and feline cardiogenic arterial thromboembolism (ATE), the
Industry development with potential relevance for veterinary professionals, companion animal care, and animal health stakeholders.
Home → Products & Science → Research & Development With purpose-driven commitment to addressing animals’ unmet medical needs, our R&D programs are fueled
New university findings highlight potential implications for veterinary patients, treatment, and veterinary practice.
Researchers at Cornell University College of Veterinary Medicine have reported new findings related to treatment. The report, centered on “Stroke test tech r...
Clinical evidence update from Research in veterinary science
Necrotic enteritis (NE), primarily caused by Clostridium perfringens (CP) type G, poses a significant threat to broiler health and performance, especially
New university findings highlight potential implications for dogs, therapy, and veterinary practice.
Researchers at Virginia-Maryland College of Veterinary Medicine have reported new findings related to therapy. The report, centered on “How one rescue dog fo...
New university findings highlight potential implications for equine, cardiology, and veterinary practice.
Researchers at Washington State University College of Veterinary Medicine have reported new findings related to cardiology. The report, centered on “WSU welc...
Clinical evidence update from Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Objective: To evaluate the antiviral effect, clinical efficacy, safety and tolerability of pixavir marboxil in adult patients with acute, uncomplicated
Clinical evidence update from Journal of the American Veterinary Medical Association
To evaluate clinical response and fecal biomarkers in dogs with tylosin-responsive enteropathy (TRE) treated with oral fecal microbiota transplantation
Industry development with potential relevance for veterinary professionals, companion animal care, and animal health stakeholders.
ATLANTA, July 22, 2026 (GLOBE NEWSWIRE) -- Exubrion Therapeutics ® , the company behind Synovetin OA ® , has promoted Gregory Taglialatela, MBA, to Chief
New university findings highlight potential implications for veterinary patients, one health, and veterinary practice.
Researchers at Mississippi State University College of Veterinary Medicine have reported new findings related to one health. The report, centered on “CVM Sum...
